CDC42 and cancer: If this putative scaffolding function plays a role in SSeCKS’ ability to suppress metastasis, this implies that the loss of SSeCKS in advanced cancer [19] facilitates metastatic cell motility parameters (e.g.- directional chemotaxis and invasiveness) through the selective activation of Cdc42 and its cytoskeletal remodeling pathways.